The Bio21 Institute has strategic relationships with a range of industry tenants from the R & D group of Australia's largest biopharmaceutical company - CSL Limited, to diverse start-up companies residing in the Institute's Incubator and Business Centre.

Our industry tenants include:

• CSL Limited R & D group who are focused on therapeutic discovery
• BioScreen Medical who focus on microbial diagnostics
• Sienna Cancer Diagnostics who focus on molecular biomarkers for specific tumours
• Patrys Ltd is focused on natural human antibodies against human disease
• AT-Bio Pty Ltd who are developing small molecule western medicines for global markets

• TechNyou is a technology information service that provides balanced and factual information on emerging technologies to help the public make informed choices

• Tecniplast Australia who market systems for both terrestrial and aquatic environments, laminar flow, wash and automation technologies to the animal science community throughout Australia and New Zealand
• Prana Biotechnology Limited Chemistry R & D Laboratory who develop disease modifying therapeutics for the treatment of common neurological disorders, with a focus upon Alzheimer's, Parkinson's and Huntington's disease.
  

Back to top